Non-Steroidal Topical Therapies: Changing Psoriasis and Atopic Dermatitis Treatment

In this interview, Dr Linda Stein Gold shares her presentation at the 2023 Fall Clinical Conference on the the influence of non-steroidal topical therapies on psoriasis and atopic dermatitis. Dr Stein Gold discusses the shift from traditional treatments to newer non-steroidal options, focusing on their mechanisms, safety, and effectiveness.

Linda F Stein Gold, MD, is director of research and head of the Division of Dermatology for the Henry Ford Health System.

Interview Questions:

1.    Can you give us an overview of what was covered during your session at the Fall Clinical Dermatology 2023?

2.    Which non-steroidal topical therapies are changing the landscape of psoriasis and atopic dermatitis treatment, and how are they distinct from traditional approaches?

3.    What are the mechanisms of action for these therapies, and how do they target the root causes of these skin conditions?

4.    How have these therapies affected patient management and outcomes in terms of safety and long-term effectiveness?

5.    What considerations should healthcare professionals remember when using or recommending non-steroidal therapies, and how do they fit into a comprehensive treatment plan?

6.    Can you highlight any current research or potential future advancements in non-steroidal topical therapies for psoriasis and atopic dermatitis, and their implications for dermatology?

7.    Are there any tips or insights you would like to share with your dermatology colleagues regarding non-steroidal topical therapies in psoriasis and atopic dermatitis?